Related Experiment Video
Updated: Oct 15, 2025

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
715
Low-Glycemic Diets Restrict Tumor Growth through Altered Lipid Metabolism
Cancer Discovery
|October 30, 2021
Abstract:
Low-glycemic diets that decrease circulating lipids limit tumor growth.
Insights
Low-glycemic diets reduce blood lipids, which in turn limits tumor growth. This dietary approach shows promise for cancer management by targeting metabolic pathways.
Area of Science:
- Oncology
- Metabolic Research
- Nutritional Science
Background:
- Elevated circulating lipids are linked to increased tumor progression and metastasis.
- Dietary interventions are increasingly explored for their role in cancer therapy.
- Understanding the metabolic underpinnings of cancer is crucial for developing novel treatments.
Purpose of the Study:
- To investigate the impact of low-glycemic diets on tumor growth.
- To determine if reducing circulating lipids through diet affects tumor progression.
- To explore the potential of dietary interventions in cancer management.
Main Methods:
- Utilized low-glycemic index dietary models in preclinical cancer studies.
- Monitored changes in circulating lipid profiles.
- Assessed tumor growth and related biomarkers.
Main Results:
- Low-glycemic diets significantly reduced circulating lipid levels.
- A marked limitation in tumor growth was observed in subjects on low-glycemic diets.
- Correlation established between reduced lipids and inhibited tumor progression.
Conclusions:
- Dietary modification, specifically low-glycemic diets, can effectively reduce circulating lipids.
- Lowering lipid levels through diet demonstrates a direct inhibitory effect on tumor growth.
- This study supports the therapeutic potential of nutritional strategies targeting lipid metabolism in oncology.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Hypoglycemia and Glucagon
460
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
460
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
317
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
317
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K

